ERBB2 and breast cancer: Human epidermal growth factor receptor 2(HER2) positive breast cancer is characteristic of HER2 protein over-expression or gene amplification-account for 20-25% of newly diagnosed breast cancer approximately, and is significantly associated with poor prognosis ever before (Emi et al., 2002; Dawood et al., 2010).